Inhaled Nitric Oxide for Persistent Pulmonary Hypertension Clinical Pathway — N/IICU
Goal
To standardize the approach to treating newborns with persistent pulmonary hypertension requiring inhaled nitric oxide (iNO) in the N/IICU.
Metrics
- Number of cohort patients whose iNO management followed pathway recommendations.
- Number of cohort patients whose iNO management did not follow pathway recommendations, but for acceptable clinical reasons (determined by chart review and clinician interviews).